Subscription to La Merie Publishing’s proprietary R&D Drug Pieline Database provides 24/7 online access to information about more than 21,000 project entries (files) for therapeutic drugs on the market and on investigational drug candidates in research & development. Pre-established and free search functions allow to identify molecules according to their
Each project is specified for its Target, Therapeutic Area and R&D Phase. Use of the R&D Drug Pipeline Database is intuitive. Data sets of interest can be printed and exported as reports in Excel or Word format. Projects are being updated continuously. The R&D history of each project with online references of information sources can be viewed and printed. Sales figures of major therapeutic antibodies, proteins and peptides on the market are provided.
An advanced search function allows to combine search parameters. A scroll down menu for predefined targets and technologies conveniently selects projects of interest. By clicking on column heads of the project list, projects can be arranged in ascending or descending alphabetical or numerical order, e.g. for phase or company name.
Special Focus of the Database:
Prerequisite: Internet access
Purchase of the subscription provides a 1-year online access to the data of the R&D Drug Pipeline Database. Credentials to access the database will be sent by e-mail within 24 hours after purchase.
Benefits from the R&D Drug Pipeline Database:
Project listing in a tabular format:
Examples of Predefined Targets of the Scroll Down Menu:
Examples of Predefined Technologies of the Scroll Down Menu:
Make an enquiry before buying this Report
Please fill the enquiry form below.
Drug discovery is a process of inventing a new medication in the field of pharmaceuticals, biotechnology and pharmacology. Drug discovery is a complex, lengthycomplicated and expensive process. This process is carried out in four stages namely, target identification, target validation, high-speed screening and lead optimization. Though advanced technologies are available, success rate of drug discovery is very low and the time involved is relativ...
Chiral technology is widely spread in human life for instance, drugs for treating diseases, hair sprays, clothes and other several materials are composed of chiral molecules. The global market of chiral technology was USD 4.75 billion by 2010 and expected to reach at USD 5.83 billion by 2017 at an estimated CAGR of 3.05% between 2010 and 2017. Chiral technology market can be segmented into three sub markets: Chiral synthesis market Chiral...
Several studies are performed on a human being to check the efficacy or safety of drugs, devices or therapeutic products, and these types of research performed are known as clinical trials. These researches are carried out before drugs, devices and therapeutic products are launched into the market. They require huge investment at the initial level and in the present scenario it has become mandatory for hospitals to carry out such research...